UH Cancer Center and John A. Burns School of Medicine form initiative focused on health outcome disparities in Hawai‘i and the Pacific

The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five states
Honoring the Jon Huntsman Sr. political perspective: “I’m not a member of any party except the Cancer Party”

Mary Beckerle, a whitewater kayaker, has advice for all the folks in the cancer field: never catastrophize, never panic.

UVA Cancer Center expands prostate cancer awareness initiative

In recognition of Men’s Health Month, UVA Cancer Center is expanding “Stay in the Game,” a community-centered program to raise awareness across Virginia about prostate cancer and the importance of early screening.

June 20, 2025

Vol.51 No.24

Clinical Trials & Tribulations

Bridging the gaps in cancer care for Hispanics: Striving for equity and fairness in scientific advancements

Our Hispanic community is a vibrant and essential part of the American tapestry, contributing richly to the country’s society, culture, and economy. Yet, when it comes to healthcare, this community grapples with significant disparities, especially in cancer care.

Clairity becomes the first FDA-authorized AI platform for breast cancer prediction

Clairity Inc. received FDA De Novo authorization for CLAIRITY BREAST, a novel, image-based prognostic platform designed to predict five-year breast cancer risk from a routine screening mammogram. With this authorization, Clairity is planning to launch among leading health systems through 2025—propelling a new era of precision medicine in breast cancer.

June 06, 2025

Vol.51 No.22

Clinical Roundup

Study assesses advancing racial equity in cancer care through multimodal AI

Artera, the developer of multimodal artificial intelligence-based prognostic and predictive cancer tests, announced the publication of a validation study in the JCO Clinical Cancer Informatics on Artera’s MMAI model.

May 16, 2025

Vol.51 No.19

Clinical Roundup

Breast implant closes reconstruction gap for patients after mastectomy

Johnson & Johnson MedTech on May 13 announced the U.S. launch of MENTOR MemoryGel Enhance Breast Implants, filling a critical gap in comprehensive breast cancer care for women who have undergone a mastectomy.

May 16, 2025

Vol.51 No.19

UH Cancer Center and John A. Burns School of Medicine form initiative focused on health outcome disparities in Hawai‘i and the Pacific

YOU MAY BE INTERESTED IN

The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five states
Honoring the Jon Huntsman Sr. political perspective: “I’m not a member of any party except the Cancer Party”

UVA Cancer Center expands prostate cancer awareness initiative

Bridging the gaps in cancer care for Hispanics: Striving for equity and fairness in scientific advancements

Clairity becomes the first FDA-authorized AI platform for breast cancer prediction

Study assesses advancing racial equity in cancer care through multimodal AI

Breast implant closes reconstruction gap for patients after mastectomy

Renew today!

Subscriber content

Never miss an issue!

Login

UH Cancer Center and John A. Burns School of Medicine form initiative focused on health outcome disparities in Hawai‘i and the Pacific

YOU MAY BE INTERESTED IN

The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five statesHonoring the Jon Huntsman Sr. political perspective: “I’m not a member of any party except the Cancer Party”

UVA Cancer Center expands prostate cancer awareness initiative

Bridging the gaps in cancer care for Hispanics: Striving for equity and fairness in scientific advancements

Clairity becomes the first FDA-authorized AI platform for breast cancer prediction

Study assesses advancing racial equity in cancer care through multimodal AI

Breast implant closes reconstruction gap for patients after mastectomy

Never miss an issue!

Login

The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five states
Honoring the Jon Huntsman Sr. political perspective: “I’m not a member of any party except the Cancer Party”